Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The UPMC OPtimizing Treatment and Impact of Monocolonal antIbodieS Through Evaluation for COVID-19 Trial

NCT04790786 is registered in ClinicalTrials.gov with Erin McCreary as lead sponsor.

NCT NCT04790786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04790786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The UPMC OPtimizing Treatment and Impact of Monocolonal antIbodieS Through Evaluation for COVID-19 Trial
Lead sponsor
Erin McCreary
Phase
Phase 4
Overall status
Terminated
Start date
March 10, 2021
Completion date
June 16, 2022
Enrollment
4,571 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19